These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 38531156

  • 1. Myxomatous mitral valve disease and associated pulmonary hypertension might increase serum angiopoietin-2 in dogs.
    Yu H, Lee D, Chae Y, Choi M, Lee Y, Yun T, Kang BT, Yang MP, Kim H.
    Am J Vet Res; 2024 Jun 01; 85(6):. PubMed ID: 38531156
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Platelet hyperresponsiveness and increased platelet-neutrophil aggregates in dogs with myxomatous mitral valve disease and pulmonary hypertension.
    Duler L, Visser L, Nguyen N, Johnson LR, Stern JA, Li RHL.
    J Vet Intern Med; 2024 Jun 01; 38(4):2052-2063. PubMed ID: 38773707
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Symmetric dimethylarginine in dogs with myxomatous mitral valve disease at various stages of disease severity.
    Valente C, Guglielmini C, Domenech O, Contiero B, Zini E, Poser H.
    PLoS One; 2020 Jun 01; 15(9):e0238440. PubMed ID: 32870923
    [Abstract] [Full Text] [Related]

  • 6. Tricuspid annular plane systolic excursion in dogs with myxomatous mitral valve disease with and without pulmonary hypertension.
    Poser H, Berlanda M, Monacolli M, Contiero B, Coltro A, Guglielmini C.
    J Vet Cardiol; 2017 Jun 01; 19(3):228-239. PubMed ID: 28579307
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Plasma humanin as a prognostic biomarker for canine myxomatous mitral valve disease: a comparison with plasma NT-roBNP.
    Mangkhang K, Punyapornwithaya V, Tankaew P, Pongkan W, Chattipakorn N, Boonyapakorn C.
    Pol J Vet Sci; 2018 Dec 01; 21(4):673-680. PubMed ID: 30605282
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic value of atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP) and their correlation with lipoproteins in dogs with myxomatous mitral valve disease.
    Khaki Z, Nooshirvani P, Shirani D, Masoudifard M.
    BMC Vet Res; 2022 Dec 23; 18(1):448. PubMed ID: 36564735
    [Abstract] [Full Text] [Related]

  • 11. Increased serum C-reactive protein concentrations in dogs with congestive heart failure due to myxomatous mitral valve disease.
    Reimann MJ, Ljungvall I, Hillström A, Møller JE, Hagman R, Falk T, Höglund K, Häggström J, Olsen LH.
    Vet J; 2016 Mar 23; 209():113-8. PubMed ID: 26831162
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Two-dimensional echocardiographic estimates of left atrial function in healthy dogs and dogs with myxomatous mitral valve disease.
    Dickson D, Caivano D, Matos JN, Summerfield N, Rishniw M.
    J Vet Cardiol; 2017 Dec 23; 19(6):469-479. PubMed ID: 29111284
    [Abstract] [Full Text] [Related]

  • 14. Retrospective evaluation of the utility of shock index to determine the presence of congestive heart failure in dogs with myxomatous mitral valve disease (2019-2021): 98 cases.
    Matson H, Llewellyn EA.
    J Vet Emerg Crit Care (San Antonio); 2024 Dec 23; 34(3):231-237. PubMed ID: 38809224
    [Abstract] [Full Text] [Related]

  • 15. Markers of Oxidative Stress in Dogs with Myxomatous Mitral Valve Disease are Influenced by Sex, Neuter Status, and Serum Cholesterol Concentration.
    Reimann MJ, Häggström J, Møller JE, Lykkesfeldt J, Falk T, Olsen LH.
    J Vet Intern Med; 2017 Mar 23; 31(2):295-302. PubMed ID: 28132441
    [Abstract] [Full Text] [Related]

  • 16. Perivascular inflammatory cells and their association with pulmonary arterial remodelling in dogs with pulmonary hypertension due to myxomatous mitral valve disease.
    Sakarin S, Rungsipipat A, Surachetpong SD.
    Vet Res Commun; 2023 Sep 23; 47(3):1505-1521. PubMed ID: 36976445
    [Abstract] [Full Text] [Related]

  • 17. Prognostic value of pulmonary vascular resistance estimated by echocardiography in dogs with myxomatous mitral valve disease and pulmonary hypertension.
    Yuchi Y, Suzuki R, Yasumura Y, Saito T, Teshima T, Matsumoto H, Koyama H.
    J Vet Intern Med; 2023 Sep 23; 37(3):856-865. PubMed ID: 36994902
    [Abstract] [Full Text] [Related]

  • 18. The diagnostic relevance of NT-proBNP and proANP 31-67 measurements in staging of myxomatous mitral valve disease in dogs.
    Wolf J, Gerlach N, Weber K, Klima A, Wess G.
    Vet Clin Pathol; 2013 Jun 23; 42(2):196-206. PubMed ID: 23614733
    [Abstract] [Full Text] [Related]

  • 19. How accurate are NT-proBNP, ANP, and cTnI levels in diagnosing dogs with myxomatous mitral valve disease?
    Chanmongkolpanit K, Riengvirodkij N, Channgam P, Kaenchan P, Buayam W, Janhirun Y, Phonarknguen R, Tansakul M, Sakcamduang W.
    Open Vet J; 2024 Jun 23; 14(6):1426-1441. PubMed ID: 39055758
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.